FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Drug Shortage Mitigation Guidance

[ Price : $8.95]

FDA issues a draft guidance recommending to applicants and manufacturers drug shortage information to be communicated to FDA to as...

Lab Tests Could be in Preparedness Bill

[ Price : $8.95]

The political newsletter Roll Call says efforts to reauthorize a pandemic preparedness bill are likely to include a debate over gr...

QuVa Pharma FDA-483

[ Price : $8.95]

FDA releases the form FDA-483 with three observations issued following an inspection at the Sugar Land, TX-based QuVa Pharma outso...

CDER is in Growth Mode from Hiring Spree: Cavazzoni

[ Price : $8.95]

CDER director Patrizia Cavazzoni tells the Alliance for a Stronger FDA that the Center is in growth mode after the user fee reauth...

FDA OKs Synapse Bio PMA for Breathing System

[ Price : $8.95]

FDA approves a Synapse Biomedical PMA for the NeuRx Diaphragm Pacing System for use in patients with spinal cord injuries who rely...

FDA on Pharmacodynamic Biomarker Research

[ Price : $8.95]

FDA outlines research into potential pharmacodynamic biomarkers for biosimilar development.

Docket Open for Opioids Home Disposal REMS

[ Price : $8.95]

Federal Register notice: FDA establishes a docket to obtain information and comments to help assess whether in-home disposal produ...

FDA Selecting Fall Covid Vaccine Make-up in June

[ Price : $8.95]

CBER director Peter Marks says Covid-19 vaccine makers will be given advice in June on the next booster vaccine composition for fa...

Phathom Plans to Resubmit NDA, and Supplemental NDA

[ Price : $8.95]

Phathom Pharmaceuticals says it will resubmit an NDA for vonoprazan for treating erosive esophagitis, and a post-approval suppleme...

2 Pfizer sNDA Submitted for Lung Cancer Drugs

[ Price : $8.95]

FDA accepts for review two Pfizer Supplemental NDAs for Braftovi (encorafenib) and Mektovi (binimetinib) and their use in patients...